Therapeutic Asset Ratings

615 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Hrs-5041 Metastatic Prostate Carcinoma	Fudan University	P2	CCC (53)
Hrs-6209 Breast Neoplasm	Fudan University	P2	CCC (53)
Hrs-6209 Hormone Receptor Negative Tumor	Fudan University	P2	CCC (53)
Hrs-6209 Hormone Receptor Positive Tumor	Fudan University	P2	CCC (53)
Hrs-6209 Triple-Negative Breast Carcinoma	Fudan University	P2	CCC (53)
Hrs-7058 Colorectal Cancer	Fudan University	P2	CCC (53)
Huaier Granule Proteinuria	Fudan University	P2	CCC (53)
ibi354 Breast Neoplasm	Fudan University	P2	CCC (53)
ibi354 Hormone Receptor Negative Tumor	Fudan University	P2	CCC (53)
ibi354 Hormone Receptor Positive Tumor	Fudan University	P2	CCC (53)
ibi354 Triple-Negative Breast Carcinoma	Fudan University	P2	CCC (53)
Ifosfamide Paget Disease, Extramammary	Fudan University	P2	CCC (53)
Ifosfamide Penile Cancer	Fudan University	P2	CCC (53)
Ifosfamide Testicular Cancer	Fudan University	P2	CCC (53)
Ifosfamide Urachal Cancer	Fudan University	P2	CCC (53)
IMMUNOGLOBULIN G1, ANTI-(HUMANIZED MOUSE MONOCLONAL HR3 .BETA.1 CHAIN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR), DISULFIDE WITH HUMANIZED MOUSE MONOCLONAL HR3 .KAPPA.-CHAIN, DIMER Pancreatic Neuroendocrine Neoplasm	Fudan University	P2	CCC (53)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER Hormone Receptor Negative Tumor	Fudan University	P2	CCC (53)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER Hormone Receptor Positive Tumor	Fudan University	P2	CCC (53)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Maintenance Therapy	Fudan University	P2	CCC (53)
Inetetamab Inetetamab	Fudan University	P2	CCC (53)
Inetetamab SKB264	Fudan University	P2	CCC (53)
Inno-206 HR+HER2- Breast Cancer	Fudan University	P2	CCC (53)
Inno-206 Maintenance Therapy	Fudan University	P2	CCC (53)
Iparomlimab Acral Melanoma	Fudan University	P2	CCC (53)
Iparomlimab HR+HER2- Breast Cancer	Fudan University	P2	CCC (53)

Showing 276 to 300 of 615 assets

PreviousPage 12 of 25Next